Skip to content

Multicenter Study of Tetanus Patients in Fujian Province of China

Multicenter Study of Tetanus Patients in Fujian Province of China

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04165928
Enrollment
95
Registered
2019-11-18
Start date
2018-07-01
Completion date
2019-10-31
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tetanus

Keywords

neonatal tetanus, tetanus immunization program, drug-induced, tetanus antitoxin, critical care medicine, artificial airway

Brief summary

Background: Tetanus is a life-threatening disease in developing countries, and accompanied by a high mortality rate. China is the world's largest developing country, and Fujian Province is a typical coastal province in China with a relatively developed economy. Therefore, the purpose of this study was to investigate the epidemiology, incidence and management of tetanus in Fujian Province and to understand the current treatment and prognosis of tetanus patients in China. Methods: This was a retrospective multicenter observational study of patients who presented with a clinical diagnosis of tetanus at 5 general hospitals in Fujian. Data was analyzed using computer software system.

Interventions

None listed

Sponsors

Fujian Provincial Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* This study included all patients of all age groups and both sexes who presented with a clinical diagnosis of tetanus.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
Outcomes of the tetanus patients2008-01-01~2018-10-31The survival data of tetanus patients.

Secondary

MeasureTime frameDescription
The hospitalization time.2008-01-01~2018-10-31The total length of hospitalization and the length of stay in the ICU.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026